You are here

Article info

Article menu
Asthma
Original article
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone

Authors

  1. Correspondence to Dr Eric D Bateman, Division of Pulmonology, Department of Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town 7937, South Africa; Eric.Bateman{at}uct.ac.za
View Full Text

Citation

Bateman ED, O'Byrne PM, Busse WW, et al
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone
Thorax 2014;69:312-319.

Publication history

  • Received March 19, 2013
  • Revised October 28, 2013
  • Accepted October 31, 2013
  • First published November 19, 2013.
Online issue publication 
September 01, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/